FOLH1 and posterior cortical atrophy: Of late, the US Food and Drug Administration has approved 68Ga-PSMA-11 (Carlucci et al., 2021) and 18F-DCFPyL (Song et al., 2022) as novel PET imaging tracers for PCa.